XML 26 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock Based Compensation
6 Months Ended
Jul. 01, 2017
Stock Based Compensation [Abstract]  
Stock Based Compensation
Note J – Stock Based Compensation

The Company accounts for its stock based awards in accordance with Accounting Standards Codification subtopic 718-10, Compensation ("ASC 718-10"), which requires a fair value measurement and recognition of compensation expense for all share-based payment awards made to its employees and directors, including employee stock options and restricted stock awards. The Company estimates the fair value of stock options granted using the Black-Scholes valuation model. This model requires the Company to make estimates and assumptions including, among other things, estimates regarding the length of time an employee will retain vested stock options before exercising them, the estimated volatility of our common stock price and the number of options that will be forfeited prior to vesting. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. Changes in these estimates and assumptions can materially affect the determination of the fair value of stock-based compensation and consequently, the related amount recognized in the Company's consolidated statements of operations.

As of July 1, 2017, the Company had one stock option plan, The Eastern Company 2010 Executive Stock Incentive Plan (the "2010 Plan"), for officers, other key employees, and non-employee directors.  Incentive stock options granted under the 2010 Plan must have exercise prices that are not less than 100% of the fair market value of the Company's common stock on the dates the stock options are granted.  Restricted stock awards may also be granted to participants under the 2010 Plan with restrictions determined by the Compensation Committee of the Company's Board of Directors.  Under the 2010 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Company's Board of Directors. In the second quarter of 2017, 25,000 stock options were granted and no stock options or restricted stock were granted in the second quarter of 2016 which are subject to meeting performance measurements.

The 2010 Plan also permits the issuance of Stock Appreciation Rights ("SARs").  The SARs are in the form of an option with a cashless exercise price equal to the fair value of the Company's common stock at the date of grant.  During the second quarter of 2017, the Company issued 87,500 SARs at an exercise price of $21.10.  The SARs will become fully vested after five years and some are subject to meeting certain performance measurements.  When exercised, the Company will issue shares of Company common stock with a value equal to the difference between the closing price of the Company's common stock on the date of exercise and the exercise price of the SAR's.

Stock-based compensation expense in connection with SARs granted to employees and directors in the second quarter of fiscal year 2017 was approximately $55,584.

As of July 1, 2017, there were 325,500 shares of common stock reserved and available for future grant under the above noted 2010 Plan.

The following tables set forth the outstanding stock options and SARs for the period specified:

  
Three Months Ended
July 1, 2017
  
Year Ended
December 31, 2016
 
  
Shares
 
Weighted - Average Exercise Price
  
Shares
 
Weighted - Average Exercise Price
 
Outstanding at beginning of period
  
62,000
  
$
19.10
   
--
  
$
--
 
Issued
  
112,500
   
21.10
   
--
   
--
 
Outstanding at end of period
  
174,500
   
20.39
   
--
   
--
 
 
SARs  and Options Outstanding and Exercisable
Range of Exercise Prices
Outstanding as of
July 1, 2017
Weighted- Average Remaining Contractual Life
Weighted- Average Exercise Price
Exercisable as of
July 1, 2017
Weighted- Average Remaining Contractual Life
Weighted- Average Exercise Price
$19.10-21.10
174,500
4.7
$20.39
--
--
--
 
As of July 1, 2017, outstanding SARs and options had an intrinsic value of $2,204,525.